Schedule 13G ownership disclosure

SCILEX HOLDING CO

Common Stock par value $0.0001 per share · CUSIP: 80880W106

Event date: 2025-03-31

Filing-level shares
732,717.00
Percent of class
9.9%
  • Oramed Pharmaceuticals Inc.

    Shares: 732,717.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-041073
Form type
SCHEDULE 13G/A
Filer
ORAMED PHARMACEUTICALS INC.
CIK
CIK 1176309
Filed
May 08, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub